IQ EQ Fund Management’s Beam Therapeutics BEAM Stock Holding History

IQ EQ Fund Management’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.6M	Sell	455,954 -32,463	-7%	-$980K	1%	26
2026 Q1	$11.6M	Sell	488,417 -45,146	-8%	-$1.25M	0.88%	29
2025 Q4	$14.8M	Buy	533,563 +150,032	+39%	+$3.83M	1.02%	24
2025 Q3	$9.31M	Buy	383,531 +188,243	+96%	+$3.74M	0.63%	42
2025 Q2	$3.32M	Buy	195,288 +130,036	+199%	+$2.26M	0.3%	94
2025 Q1	$1.27M	Buy	65,252 +33,054	+103%	+$866K	0.15%	158
2024 Q4	$799K	Buy	32,198 +19,080	+145%	+$487K	0.09%	209
2024 Q3	$321K	Buy	13,118 +3,815	+41%	+$98.6K	0.03%	285
2024 Q2	$218K	Buy	+9,303	New	+$228K	0.02%	289

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

IQ EQ Fund Management's BEAM Position: Q2 2026 in Review

IQ EQ Fund Management reduced its Beam Therapeutics (BEAM) stake by 6.6% in Q2 2026, selling an estimated $980K and leaving 455,954 shares worth $15.6M. The position accounts for 1% of the portfolio, ranked #26.

IQ EQ Fund Management first reported a position in BEAM in Q2 2024 and has held it in 9 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

IQ EQ Fund Management held 455,954 shares of Beam Therapeutics worth $15.6M as of Q2 2026.
IQ EQ Fund Management sold 32,463 Beam Therapeutics shares in Q2 2026, an estimated $980K.
Beam Therapeutics made up 1% of IQ EQ Fund Management's portfolio in Q2 2026, its #26 holding.
IQ EQ Fund Management first reported a position in Beam Therapeutics in Q2 2024 and has held it in 9 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.